We are thrilled to announce Robert S. Langer, co-founder of Moderna, has joined our advisory board.

In our latest fireside chat, we sat down with Dan Gusz, Chief of Staff at Signos, to discuss some of the common challenges sponsors see when collaborating with CROs along with the benefits of being cutting-edge in technology when approaching clinical trials.

We're excited to announce the completion of enrollment in Thirty Madison's personalized dermatology care pilot study that we're delivering.

Amiel Kollek, senior software engineer at Lindus Health, reflects on the use of AI in clinical trials and how it can be used to bring about the right kind of change.

Drug discovery is becoming more expensive and producing less results than ever before (Eroom's Law) —why? One of the ballooning costs is clinical trials. Our co-founder Meri Beckwith sits down with Dr. Mustafa Sultan, creator of The Big Picture Medicine Podcast, to talk through how we're building the anti-CRO (Lindus Health!) to solve this problem.

M. Jason Brooke, Attorney and Managing Member at Brooke & Associates, was kind enough to stop by our virtual fireplace to discuss the FDA’s latest draft guidances on 510k submissions and share tips on how medical device companies could best navigate them.